Certior Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,342
Closed -$510K 151
2026
Q1
$510K Buy
3,342
+21
+0.6% +$3.22K 0.33% 59
2025
Q4
$458K Buy
3,321
+232
+8% +$30.4K 0.31% 63
2025
Q3
$396K Sell
3,089
-201
-6% -$24.5K 0.26% 83
2025
Q2
$398K Sell
3,290
-55
-2% -$6.2K 0.3% 77
2025
Q1
$373K Buy
3,345
+60
+2% +$6.39K 0.3% 80
2024
Q4
$320K Buy
+3,285
New +$350K 0.28% 92

Other funds holding NVS

Certior Financial Group's NVS Position: Q2 2026 in Review

Certior Financial Group sold out of Novartis (NVS) in Q2 2026, closing a stake of 3,342 shares — an estimated $510K sold.

Certior Financial Group first reported a position in NVS in Q4 2024 and held it in 6 quarters. The position peaked at $510K in Q1 2026. 629 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Certior Financial Group reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • Certior Financial Group sold 3,342 Novartis shares in Q2 2026, an estimated $510K.
  • Certior Financial Group first reported a position in Novartis in Q4 2024 and held it in 6 quarters.
  • Certior Financial Group's Novartis position peaked at $510K in Q1 2026.
  • 629 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Certior Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.